Drug intelligence / Profile preview

68Ga-NODAGA-AE105

Development stage
Unknown
Lead developer
Curasight
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Peptides
Administration
Intravenous
01

Overview

68Ga-NODAGA-AE105 is a radiopharmaceutical diagnostic imaging agent designed for positron emission tomography (PET). It consists of the radionuclide Gallium-68 (68Ga) chelated by NODAGA and conjugated to the peptide AE105, which is a high-affinity antagonist of the urokinase-type plasminogen activator receptor (uPAR). uPAR is frequently overexpressed in various aggressive cancers, including glioblastoma, breast, prostate, and colorectal cancers, where it facilitates cell invasion and metastasis. By binding specifically to uPAR, this tracer allows for the non-invasive visualization and quantification of uPAR expression in vivo, potentially identifying patients with poor prognosis or those eligible for uPAR-targeted therapies. The tracer is being developed commercially under the name uTRACE.

Other names
[68Ga]Ga-NODAGA-AE10568Ga-uTRACE
02

Targets

PLAUR (Urokinase plasminogen activator receptor)

Beyond the preview

Go deeper on 68Ga-NODAGA-AE105.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-NODAGA-AE105.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call